Literature DB >> 21887251

HIV incidence among men who have sex with men in China: a meta-analysis of published studies.

Hong-Min Li1, Rui-Rui Peng, Jing Li, Yue-Ping Yin, Baoxi Wang, Myron S Cohen, Xiang-Sheng Chen.   

Abstract

BACKGROUND: Men who have sex with men (MSM) have now become one of the priority populations for prevention and control of HIV pandemic in China. Information of HIV incidence among MSM is important to describe the spreading of the infection and predict its trends in this population. We reviewed the published literature on the incidence of HIV infection among MSM in China.
METHODS: We identified relevant studies by use of a comprehensive strategy including searches of Medline and two Chinese electronic publication databases from January 2005 to September 2010. Point estimate of random effects incidence with corresponding 95% confidence intervals (CI) of HIV infection was carried out using the Comprehensive Meta-Analysis software. Subgroup analyses were examined separately, stratified by study design and geographic location.
RESULTS: Twelve studies were identified, including three cohort studies and nine cross-sectional studies. The subgroup analyses revealed that the sub-overall incidence estimates were 3.5% (95% CI, 1.7%-5.3%) and 6.7% (95% CI, 4.8%-8.6%) for cohort and cross-sectional studies, respectively (difference between the sub-overalls, Q = 5.54, p = 0.02); and 8.3% (95% CI, 6.9%-9.7%) and 4.6% (95% CI, 2.4%-6.9%) for studies in Chongqing and other areas, respectively (difference between the sub-overalls, Q = 7.58, p<0.01). Syphilis infection (RR = 3.33, p<0.001), multiple sex partnerships (RR = 2.81, p<0.001), and unprotected receptive anal intercourse in the past six months (RR = 3.88, p = 0.007) represented significant risk for HIV seroconversion.
CONCLUSIONS: Findings from this meta-analysis indicate that HIV incidence is substantial in MSM in China. High incidence of HIV infection and unique patterns of sexual risk behaviors in this population serve as a call for action that should be answered with the innovative social and public health intervention strategies, and development of biological prevention strategies.

Entities:  

Mesh:

Year:  2011        PMID: 21887251      PMCID: PMC3162552          DOI: 10.1371/journal.pone.0023431

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The HIV epidemic in China continues to grow, expanding well beyond injection drug users (IDUs) and former plasma donors (FPDs), the first groups to suffer the spread of HIV [1]. Men who have sex with men (MSM) have now become one of the priority populations for prevention and control of HIV pandemic in China. While MSM account for only 2–4% of the Chinese adult male population [2], they comprised an estimated 32.5% of about 48,000 new HIV cases in 2009 [3]. Alarmingly, MSM represented 0.4% of patients with HIV in 2005 and 12.2% of the patients in 2007 [1], [2]. The aim of this study is to provide a comprehensive review and analysis of the scientific and empirical literature (both in English and Chinese) on the measurement of HIV incidence in Chinese MSM. In addition, we sought to identify risk factors associated with the incidence, to improve the existing programmatic and policy efforts targeting this population.

Results

Study inclusion

We identified 83 relevant articles in English and 24 in Chinese for evaluation. Out of these, 5 in English [4]–[8] and 6 in Chinese [9]–[14] met eligibility criteria. One article by Li et al included two independent studies reporting the incidence estimate of years 2005 and 2006, respectively [4]. One article by Han et al included three different studies from 2006, 2007 and 2008 [9], but their data from 2006 was published earlier elsewhere [10], so only data from 2007 and 2008 in Han's article were included in this analysis. The articles by Li DL et al [8] and Ruan et al [7] used the same cohort of subjects, and Li's data was used for analysis of predictors associated with HIV seroconversion, and Ruan's data was used for analysis of incidence estimates. A total of 12 studies from 11 articles consisting of more than 8000 men were included in this analysis, of which three were cohort studies [5]–[8] and nine were cross-sectional studies [4], [9]–[14]. Three studies were from north China (Beijing) [4], [7], [8], one from northwest China (Liaoning) [5], one from northwest China (Xinjiang) [13], three from east China (Jiangsu) [6], [11], [12], and four from southwest China (Chongqing) [9], [10], [14]. Characteristics of the 12 studies are present in Table 1. There was no statistically significant publication bias (Begg rank correlation test, p = 0.19), but a substantial heterogeneity among the included studies was noted (Q test, p<0.001; I2 = 73.58).
Table 1

Summarized information of the studies included in meta-analysis.

Study year(s)Study locationSettinga Recruitment method(s)b Sample sizeTesting method used for estimating HIV incidencec Background HIV prevalence (%)Reported HIV incidence per 100 persons or 100 person-years
Feng LG, et al2006ChongqingInternet, MSM bars, parks and bathhousesSBR1000BED-CEIA10.48.0
Han M, et al (1)d 2007ChongqingInternet, MSM bars, parks and bathhousesSBR1044BED-CEIA12.59.1
Han M, et al (2)d 2008Chongqing945BED-CEIA15.89.4
Hu HY, et al (1)e 2008JiangsuNRf NRf 948RT-PCRNRf 5.6
Hu HY, et al (2)e 2008JiangsuNRf BED-CEIANRf 7.5
Li SW, et al (1)d 2005BeijingInternet, MSM bars, parks and bathhousesIBR526BED-CEIA3.22.9
Li SW, et al (2)d 2006Beijing541BED-CEIA4.83.6
Zhang Y, et al2007XinjiangInternetINR143BED-CEIA6.56.7
Wang MJ, et al2006ChongqingInternet, MSM bars, bathhouses, saunas, massage parlorsSBR, IBR1000BED-CEIA10.37.3
Ruan YH, et al2006–2008BeijingInternet, MSM bars, bathhouses, saunas, massage parlorsIBR, SBR437EIA-WB4.82.6
Xu JJ, et al2006–2007LiaoningNRf SBR122EIA-WB5.75.4
Yang HT, et al2007–2008JiangsuNRf RDS397EIA-WB4.65.1

The places where the study subjects were recruited.

SBR, snowballing recruitment; RDS, respondent-driven sampling recruitment; IBR, internet-based recruitment; and SNR, social network recruitment.

BED-CEIA, BED capture enzyme immunoassay; RT-PCR, pooled RNA reverse transcription-PCR amplification assay; EIA-WB, enzyme immunoassay screening followed by Western blot confirmation.

(1) and (2) represent different studies from the same article.

(1) and (2) represent different studies from the same first author.

NR, not reported in original paper.

The places where the study subjects were recruited. SBR, snowballing recruitment; RDS, respondent-driven sampling recruitment; IBR, internet-based recruitment; and SNR, social network recruitment. BED-CEIA, BED capture enzyme immunoassay; RT-PCR, pooled RNA reverse transcription-PCR amplification assay; EIA-WB, enzyme immunoassay screening followed by Western blot confirmation. (1) and (2) represent different studies from the same article. (1) and (2) represent different studies from the same first author. NR, not reported in original paper.

Incidence estimation

The individual incidence rate varied from 2.6% (95% CI, 1.1%–4.1%) to 9.4% (95% CI, 6.3%–12.5%), Figure 1. The subgroup meta-analyses revealed that incidence estimates were 3.5% (95% CI, 1.7%–5.3%) and 6.7% (95% CI, 4.8%–8.6%) for cohort and cross-sectional studies, respectively (difference between the sub-overalls, Q = 5.54, p = 0.02); and 8.3% (95% CI, 6.9%–9.7%) and 4.6% (95% CI, 2.4%–6.9%) for studies in Chongqing and other areas, respectively (difference between the sub-overalls, Q = 7.58, p<0.01), Figure 2. For the subgroups, the random effects incidence estimates were nearly identical to the crude pooled incidence estimate of 3.6% (95% CI, 2.2%–5.0%) and 7.6% (95% CI, 6.4%–8.8%) for the cohort and cross-sectional studies, respectively; and 8.8% (95% CI, 7.3%–10.3%) and 4.0% (95% CI, 2.2%–5.8%) for Chongqing and other areas, respectively.
Figure 1

Crude results based on meta-analysis of studies assessing HIV incidence.

Figure 2

Crude results based on meta-analysis of studies assessing HIV incidence by study design, and study location.

Risk factor analysis

Based on the five studies in which association of risk factors and incident HIV infection were reported [4]–[6], [8], [12], meta-analysis revealed that baseline syphilis infection (RR = 3.33, 95%CI, 1.97–5.62; p<0.001), multiple sex partnership (RR = 2.81, 95%CI, 1.59–4.95; p<0.001), and unprotected receptive anal intercourse in the past six months (RR = 3.88, 95%CI, 1.44–10.47; p = 0.007) were significantly associated with HIV seroconversion (Figure 3).
Figure 3

Crude results based on meta-analysis of studies assessing risk factors of HIV incidence.

Study quality

Study quality was significantly variable (Table 1). Concerns about the ability of the study sample to accurately represent the MSM population (external validity) are of concern in all studies where a convenience sample was employed. Only one of the included study [6] adopted respondent-driven sampling (RDS) recruitment, which has good representativeness, and other studies [4], [5], [7]–[10], [13], [14] included employed recruitment methods such as snowballing, social network, internet-based recruitment, and so on. Bias in detection of HIV infection (misclassification of outcome) or syphilis infection (potential risk factor) was unlikely, because assessment and confirmation of HIV or syphilis infection were conducted in the qualified laboratories using blinded methods. Information bias related to risk behaviors was obtained by self-report rather than objective measurement. The loss-to-follow-up was greater than 40% in one of 3 cohort studies [5], and participation and completeness rates were not reported or unclear in most of the cross-sectional studies, resulting in a significant attrition bias. Statistical adjustments for measured confounding factors were made in some of the included studies. Cross-sectional studies employed laboratory methods, such as BED assay and pooled RNA reverse transcription PCR (PT-PCR) amplification assay, to measure HIV incidence. However, as the dominating employed laboratory method in China, BED assay may overestimate the number of incident cases mainly because of probable misclassification of long term infection as recent HIV infection [15]–[18].

Discussion

MSM transmission of HIV is a critical and growing public health problem in China. The HIV seroprevalence rate among MSM has been reported to be 2.5% (95% CI 0.9% to 3.3%) [19]. A national study survey of more than 18,000 MSM in 61 Chinese cities in 2008 reported an HIV prevalence of 4.9%, varying from over 10% in the south-west, to 7% in the east and 4–5% along coast in the south and north-east [20]. The empirical prevalence of HIV 4.9% in 2008 is much higher than derived from 26 studies published during 2001–2008 [19]. Since the late 1990s, increasing numbers of newly diagnosed HIV infections in MSM have been observed in many countries with large and visible MSM communities [21]. Segura et al reported an incidence of 3.9% (95% CI, 2.0%–6.7%) among MSM in Buenos Aires in a cohort study during 2003 to 2004 [22]. Hurtado et al observed an increase in incidence from 2002 to 2003 in this population in Valencia, Spain [23]. Since the nationwide prospective cohort studies are not possible to include in the national surveillance program, regular meta-analyses based on the improved data from cross-sectional and prospective studies may provide important information for developing and monitoring the intervention programs, although the results from the current meta-analysis were not able to exactly represent the HIV incidence among MSM in China considering the limitations in estimation method, sampling strategy, number of studies and sample size, representativeness and coverage of rural areas, etc. With a reasonable geographic coverage consisting of Jiangsu (east China), Beijing (north China), Liaoning (northeast China), Chongqing (southwest China), and Xinjiang (northwest China), reasonable comparability of BED and prospective cohort study in estimation of incidence, and moderate quality of the studies included, the findings from our meta-analysis could a glance of HIV incidence among the particular subgroup in China. In this meta-analysis, we included 12 studies from 11 articles publishing in English or Chinese and covering 5 regions in China, making this the first systematic and comprehensive review of HIV incidence to date. The individual incidence of HIV infection included in this meta-analysis varied widely from 2.6% to 9.4%. The observed disparity reflects differences in study methods and study locations. The incidence of HIV infection among MSM is much higher than the reports in heterosexual populations. Studies in Yunnan, one of the provinces worst hit by HIV in China, reported the incidence estimates of 5.5%, 1.4%, 0.1%, and 0.2% amongst the discordant couples, female sex workers, pregnant women, and pre-marital couples, respectively [24]. HIV incidence among sexually transmitted disease clinic patients was reported to be 0.04% (95% CI, 0.02% to 0.10%) in Guangxi of China [25]. Chongqing is the largest municipality in southwest China, adjacent to Sichuan and Guizhou, provinces most affected by intravenous transmission of HIV by drug use. Chongqing has a higher HIV prevalence than the national average [26]. The increased incidence of HIV in MSM in Chongqing might reflect the combined risk from unprotected sex and unsafe injections. The results of our risk factor meta-analysis showed that baseline syphilis infection, multiple sex partnership, and unprotected receptive anal intercourse in the past six months were significantly associated with HIV seroconversion, which reflects the ‘unsafe sex’ among MSM. Such associations are consistent with findings by Xiao et al [27] and van der Bij et al [28], and offer direction for HIV prevention and control programmes. Behaviors of illegal drug use among MSM are not well known although a range of 0.1–44% was reported [29], since some MSM might be afraid of identifying themselves as IDUs. One of the included studies [5] reported that 2.8% of baseline MSM population had illegal drug use history in Shenyang. Yang X, et al reported 6.5% (65/1000) of recruited MSM had drug use history in Chongqing [30], which is much higher than other districts, and among 65 MSM who ever had drug use behavior, four ever had injection drug use in the last six months, and two admitted to have shared needles. In addition, southwest China is a region with higher HIV transmission through drug use than many other regions in China. MSM/IDU should be a dual-risk in this sub-population for HIV infection. Further studies are needed to investigate drug use behavior and needle sharing behavior among MSM to clarify the dual risk of HIV infection this subgroup. Study designs may affect results. According to the result of our subgroup meta-analysis by study design, the cohort studies cited [5]–[7] had lower HIV incidence than cross-sectional studies [9]–[14]. Prospective cohort studies accurately estimate HIV incidence if seroconversion is observed, but this method is susceptible to recruitment bias, loss to follow-up, short duration of follow-up, inclusion of essential prevention intervention(s) that modify the results, and other unanticipated factors. Cross-sectional studies have employed laboratory methods, mainly BED assays in China, to measure HIV incidence. However, the accuracy of the BED results has been extensively reviewed, and it may vary by place, time and age [18], or depend on the population sampled and storage of specimens [27]. Misclassification of BED, which can lead to overestimated HIV incidence, mainly include HIV-infected individuals under antiretroviral therapy, patients with advanced immunodeficiency, and different HIV subtypes [15], [16], [31]. However, in China many of studies on BED-based incidence estimation were conducted on surveillance samples in which the complicating factors might not be common [32], [33]. Although earlier studies indicated that the performance of BED assay on HIV-1 subtype C-infected individuals was questionable, Parekh et al [34] reported that the HIV-1 BED assay worked well with subtype C. HIV infection with subtype C has been observed among heterosexual contacts in Asian country [35]. It may be needed to evaluate the performance of BED assay in estimation of incidence for HIV-1 subtype C in China. Based on the ability of BED to discriminate recent from long-term seroconversion of HIV-1 infection among MSM, further molecular analyses can be possible to investigate the distribution of subtypes and monitor the genetic variation of the HIV epidemic in China and among MSM. Social stigma in China makes the MSM population very hard to reach. Subjects were recruited for study from internet or MSM venues [4], [7], or through snowball sampling or respondent driven sampling [6], [9], [10]. Out of 3 cohort studies one retained less than 60% [5], while another retained near 90% of the initial sample at the 12-month follow up [7]. MSM with high risk behaviors may not choose to participate in HIV monitoring programs [36]–[38]. It has been previously reported that cohort participants who returned regularly for follow-up visits were significantly less likely to report high-risk behaviors compared with those who are lost to follow-up [39]. Ruan et al reported that men who had a higher level of education were more likely to retain in the cohort [7]. It was reported from previous studies in China that more than one-third of the MSM had ever been married, and more than 70% of well-educated gays or bisexuals had got married or would marry with women [40]–[42]. Choi et al [43] showed that 28% of MSM in Beijing self-reported to ever have sex with both men and women during the last six months. Zhang et al [44] reported that 63.6% of MSM in China ever had casual male sex partners, and 50% of MSM ever had sex with women in the last year, and the high risk behaviors among this population implies that MSM might be bridge population for others for HIV transmission. Several biomedically based interventions for prevention of sexual transmission of HIV have obtained encouraging outcomes while many others are currently under way with biological and clinical investigations. Studies in several countries have shown that daily administration of two oral antiretroviral drugs, emtricitabine and tenofovir disoproxil fumarate could applied provide a significant protection against the acquisition of HIV infection by 44% among MSM [45]. This preexposure chemoprophylaxis may provide an opportunity for HIV prevention among this population, but there are still a lot of considerations or concerns in translating this evidence into intervention strategy, particularly in developing countries. An antiretroviral-based vaginal microbicide has proved reduction of HIV acquisition by 39% in women in a recent randomised controlled clinical trial in South Africa [46], but rectal microbicides remain at early stages of clinical investigation [47]. In order to curb the increasing epidemic of HIV among MSM in China, more risk-reduction intervention efforts are in urgent need and these intervention efforts should be guided by cultural and social context and be responsive to unique demographic characteristics and risk profiles of different subgroups [29]. Health education and behavioral interventions are still primary prevention measures in order to reduce the risk-taking behaviors mainly involved in anal intercourse. More innovative and structural interventions including HIV testing and counseling, treatment of other STIs, integration of STI and counseling and testing services into prevention activities remain a focus of prevention and control efforts to MSM in China. It is concluded that HIV incidence is high in MSM populations in China, and the high risk behaviors among this population implies that MSM might be bridge population for others for HIV transmission. It is assumed that MSM/IDUs are dual-risky for HIV infection, but further researches are needed. The 2007–2010 Guidelines for Prevention and Control of HIV/AIDS among Men Who Have Sex with Men includes a range of evidence-based HIV preventive measures, but few interventions have proven benefit in study with appropriate design and/or implementation, in China or elsewhere [48]. The considerable incidence of HIV infection and unique patterns of high risk behaviors in MSM in China serve as a call for action that must inspire new and innovative social and public health HIV prevention strategies. More studies may be necessary in China in future research, at least including (1) validation of cross-sectional BED assay to estimate HIV-1 incidence among patients on antiretroviral therapy and with advanced disease, and other subgroups as well; (2) validation of cross-sectional BED assay for subtype C of HIV-1; (3) development of modeling methods more appropriate for estimating HIV-1 incidence in Chinese settings; and (4) application of BED assays on molecular epidemiological studies of HIV-1 infection.

Materials and Methods

Study identification

Identification of relevant studies was carried out by 3 of the authors (HML, JL and RRP), who comprehensively searched PubMed-MEDLINE, China National Knowledge Information (CNKI) and Chinese Wanfang databases for articles published between January 2005 and September 2010. The search strategies of combining the following key words in English and their corresponding terms in Chinese were used: HIV, recent infection, acute infection, seroconversion, incidence, MSM, gay, sex between men, and China. The review of papers was conducted in two stages (Figure 4). Title and abstract review of all searched articles was completed by 2 of the authors (HML and JL). Full reports of 87 potentially relevant articles were independently reviewed by 2 of the authors (HML and RRP) to include the articles for the meta-analysis. To ensure efficiency of the search, reference lists of the articles from the archives were also examined.
Figure 4

Identification, review, and selection of studies included in the meta-analysis.

Studies that met each of the following criteria were considered eligible: (1) those estimating incidence of HIV-1 infection; (2) those with clear descriptions of study design, testing method to determine HIV infection, study location within China, and sample size; (3) those conducted among Chinese MSM; and (4) those published in English or Chinese. The criteria for exclusion are as follows: (1) those other than on HIV; (2) those not determining HIV incidence, including those related to knowledge, attitude, behavior and perception (KABP), drug resistance, or prevalence of HIV; (3) those from non-original studies; or (4) those conducted in other populations or other countries. If a study was reported in duplicate, the article published in English or published earlier or earliest was included in the analysis. Disagreements on eligibility between the reviewers were resolved through discussion to meet consensus.

Data extraction

A standardized data extraction form was used for recording information including study year, location, sample size, study design, sample recruitment method, testing algorithm used to estimate the incidence, background HIV prevalence, and reported HIV incidence of each included study (Table 2). Data extraction was completed by 2 of the authors (HML and RRP).
Table 2

Quality assessment of the studies included in meta-analysis.

StudyExternal validityInternal validity
Represen- tativenessa Sample sizeb Partici- pation ratec HIV testd Com- plete- nesse Reten- tion ratef Follow- up dura- tiong Loca- tionSelf-reportSTI testh
AgeMarital statusDrug useCondom useOther exposure
Cross-sectional studies
Feng LG, et alNRNRNANA
Han M, et al (1)i NRNRNANA
Han M, et al (2)i NRNRNANA
Hu HY, et al (1)j NRNRNANA
Hu HY, et al (2)j NRNRNANA
Li SW, et al (1)i NRNANA
Li SW, et al (2)i NRNRNANA
Zhang Y, et alNRNANA
Wang MJ, et alNRNRNANA
Cohort studies
Ruan YH, et alNA
Xu JJ, et alNA
Yang HT, et alNA

Symbol ✓ indicates the measure was adequately addressed in the study; NR = not report; NA = not applicable.

Studies received a ✓ if the sample included all eligible HIV-negative men over a defined time period and defined area, or a random or systematic sample of those men (e.g., RDS);

Studies received a ✓ if the sample size was 456 or more which is the sample size required to estimate the incidence given α = 0.05, δ = 0.02, and expected rate = 5%.

Studies received a ✓ if the percentage participation was 80% or more;

Studies received a ✓ if the outcome (HIV infection) was based on blinded laboratory testing;

Studies received a ✓ if the percentage participants in the final analysis was 80% or more for cross-sectional studies;

Studies received a ✓ if the percentage participants under successful retention when the outcome was evaluated was 70% or more for cohort studies;

Studies received a ✓ if the follow-up duration was 6-month or more for cohort studies;

Studies received a ✓ if the identification of STI was based on laboratory testing rather than self-report.

(1) and (2) represent different studies from the same article.

(1) and (2) represent two different articles from the same first author.

Symbol ✓ indicates the measure was adequately addressed in the study; NR = not report; NA = not applicable. Studies received a ✓ if the sample included all eligible HIV-negative men over a defined time period and defined area, or a random or systematic sample of those men (e.g., RDS); Studies received a ✓ if the sample size was 456 or more which is the sample size required to estimate the incidence given α = 0.05, δ = 0.02, and expected rate = 5%. Studies received a ✓ if the percentage participation was 80% or more; Studies received a ✓ if the outcome (HIV infection) was based on blinded laboratory testing; Studies received a ✓ if the percentage participants in the final analysis was 80% or more for cross-sectional studies; Studies received a ✓ if the percentage participants under successful retention when the outcome was evaluated was 70% or more for cohort studies; Studies received a ✓ if the follow-up duration was 6-month or more for cohort studies; Studies received a ✓ if the identification of STI was based on laboratory testing rather than self-report. (1) and (2) represent different studies from the same article. (1) and (2) represent two different articles from the same first author. The report included were categorized according to study design (cross-sectional study; cohort study) with corresponding testing method (BED capture enzyme immunoassay, BED-CEIA; pooled reverse transcription-PCR amplification assay, RT-PCR; enzyme immunoassay screening followed by Western blot confirmation, EIA-WB), and study location (Chongqing and other areas).

Quality assessment

A set of items (Table 1) for assessing the methodological quality of the articles was used for cross-sectional and cohort studies, respectively. The items included two separate sections to appraise external and internal validity, including biases relevant to data collection and classification in the studies. Two of the authors independently evaluated study quality, and disagreement was resolved by discussion with a third reviewer.

Statistical analysis

The reported incidence estimates were calculated as the ratios of the numbers of serconverters divided by the person-years of follow-up for cohort studies, and the maximum likelihood estimates using McDougal formula for sensitivity/specificity adjustments and Hargrove formula for specificity adjustments for cross-sectional studies [39], [49]. Weighted averages of reported incidences based on study size were calculated as crude pooled incidence statistics. We did not conduct pooled analyses as we could not get original data from the eligible papers. Point estimate of incidence with corresponding 95% confidence intervals (CI) of HIV infection were carried out using the Comprehensive Meta-Analysis software (CMA, version 2.0, Biostat Inc., Englewod, NJ, USA). Subgroup analyses based on study design and geographic location were examined separately. Heterogeneity between studies was tested with the Q test (p<0.10 indicating a statistically significant heterogeneity) and the I2 statistic (larger values showing the increasing heterogeneity, with 25% as low, 50% as moderate and 75% as high heterogeneity between studies) [50]. If the data are heterogeneous, random effects models were used for meta-analysis. The Begg rank correlation method was used to assess the potential for publication bias (p<0.05 indicating a statistically significant publication bias).
  39 in total

1.  Trends in HIV testing, serial HIV prevalence and HIV incidence among people attending a Center for AIDS Prevention from 1988 to 2003.

Authors:  I Hurtado; I Alastrue; I Ferreros; J del Amo; C Santos; T Tasa; I Hernández-Aguado; S Pérez-Hoyos
Journal:  Sex Transm Infect       Date:  2006-06-06       Impact factor: 3.519

2.  UNAIDS Reference Group on estimates, modelling and projections--statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-01-27

3.  Risk of HIV/AIDS in China: subpopulations of special importance.

Authors:  H Z Qian; Z H Qian; S H Vermund; N Wang
Journal:  Sex Transm Infect       Date:  2005-12       Impact factor: 3.519

4.  Potential bridges for HIV infection to men who have sex with men in Guangzhou, China.

Authors:  Qun He; Ye Wang; Peng Lin; Yongying Liu; Fang Yang; Xiaobing Fu; Yan Li; Baoshan Sun; Jie Li; Xixi Zhao; Jeffrey Mandel; Sheila Jain; Willi McFarland
Journal:  AIDS Behav       Date:  2006-06-27

5.  HIV incidence and associated factors in a cohort of men who have sex with men in Nanjing, China.

Authors:  Haitao Yang; Chun Hao; Xiping Huan; Hongjing Yan; Wenhui Guan; Xiaoqin Xu; Min Zhang; Weiming Tang; Na Wang; Joseph T F Lau
Journal:  Sex Transm Dis       Date:  2010-04       Impact factor: 2.830

6.  Increase of sexually transmitted infections, but not HIV, among young homosexual men in Amsterdam: are STIs still reliable markers for HIV transmission?

Authors:  A K van der Bij; I G Stolte; R A Coutinho; N H T M Dukers
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

Review 7.  MSM and HIV/AIDS in China.

Authors:  Bei Chuan Zhang; Quan Sheng Chu
Journal:  Cell Res       Date:  2005 Nov-Dec       Impact factor: 25.617

8.  Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.

Authors:  B S Parekh; D J Hu; S Vanichseni; G A Satten; D Candal; N L Young; D Kitayaporn; L O Srisuwanvilai; S Rakhtam; R Janssen; K Choopanya; T D Mastro
Journal:  AIDS Res Hum Retroviruses       Date:  2001-03-20       Impact factor: 2.205

9.  High levels of unprotected sex with men and women among men who have sex with men: a potential bridge of HIV transmission in Beijing, China.

Authors:  Kyung-Hee Choi; David R Gibson; Lei Han; Yaqi Guo
Journal:  AIDS Educ Prev       Date:  2004-02

10.  The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates.

Authors:  R Brookmeyer; T Quinn; M Shepherd; S Mehendale; J Rodrigues; R Bollinger
Journal:  Am J Epidemiol       Date:  1995-10-01       Impact factor: 4.897

View more
  50 in total

1.  Reconstituting the epidemic history of HIV strain CRF01_AE among men who have sex with men (MSM) in Liaoning, northeastern China: implications for the expanding epidemic among MSM in China.

Authors:  Minghui An; Xiaoxu Han; Junjie Xu; Zhenxing Chu; Manhong Jia; Hao Wu; Lin Lu; Yutaka Takebe; Hong Shang
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

2.  PORP vs. TORP: a meta-analysis.

Authors:  Huiqian Yu; Yingzi He; Yusu Ni; Yunfeng Wang; Na Lu; Huawei Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-12       Impact factor: 2.503

3.  HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China.

Authors:  Zunyou Wu; Jie Xu; Enwu Liu; Yurong Mao; Yan Xiao; Xinhua Sun; Yufen Liu; Yan Jiang; Jennifer M McGoogan; Zhi Dou; Guodong Mi; Ning Wang; Jiangping Sun; Zhongfu Liu; Lu Wang; Keming Rou; Lin Pang; Wenge Xing; Juan Xu; Shuo Wang; Yan Cui; Zhijun Li; Marc Bulterys; Wen Lin; Jinkou Zhao; Ray Yip; You Wu; Yang Hao; Yu Wang
Journal:  Clin Infect Dis       Date:  2013-04-11       Impact factor: 9.079

4.  Editorial commentary: China, HIV, and syphilis among men who have sex with men: an urgent call to action.

Authors:  Kathryn E Muessig; Myron S Cohen
Journal:  Clin Infect Dis       Date:  2013-04-11       Impact factor: 9.079

5.  Earlier anal sexarche and co-occurring sexual risk are associated with current HIV-related risk behaviors among an online sample of men who have sex with men in Asia.

Authors:  Doug H Cheung; Christian Suharlim; Thomas E Guadamuz; Sin How Lim; Stuart Koe; Chongyi Wei
Journal:  AIDS Behav       Date:  2014-12

6.  Accessing HIV testing and treatment among men who have sex with men in China: a qualitative study.

Authors:  Chongyi Wei; Hongjing Yan; Chuankun Yang; H Fisher Raymond; Jianjun Li; Haitao Yang; Jinkou Zhao; Xiping Huan; Ron Stall
Journal:  AIDS Care       Date:  2013-08-02

7.  Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China.

Authors:  Yue Chen; Ning Li; Tong Zhang; Xiaojie Huang; Fangping Cai; Nathan Vandergrift; Ruolei Xin; Zhefeng Meng; Xiaoyan Zhang; Chunlai Jiang; Xiaoning Xu; David C Montefiori; Feng Gao; Hao Wu
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

8.  Experiences and correlates of HIV self-testing among men who have sex with men in Jiangsu province, China.

Authors:  Hongjing Yan; Haitao Yang; H Fisher Raymond; Jianjun Li; Ling-En Shi; Xiping Huan; Chongyi Wei
Journal:  AIDS Behav       Date:  2015-03

9.  Predictors of HIV testing among men who have sex with men in a large Chinese city.

Authors:  Lan Zhang; Yan Xiao; Rongrong Lu; Guohui Wu; Xianbin Ding; Han-zhu Qian; Willi McFarland; Yuhua Ruan; Sten H Vermund; Yiming Shao
Journal:  Sex Transm Dis       Date:  2013-03       Impact factor: 2.830

10.  Sexual Stigma, Coping Styles, and Psychological Distress: A Longitudinal Study of Men Who Have Sex With Men in Beijing, China.

Authors:  Kyung-Hee Choi; Wayne T Steward; Pierre Miège; Esther Hudes; Steven E Gregorich
Journal:  Arch Sex Behav       Date:  2015-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.